Skip to main content

Pharmacy

By Jeff Lagasse | 04:25 pm | May 15, 2023
Medicare annual spending on lecanemab's medication costs alone would place it among the most expensive Part B medications.
By Jeff Lagasse | 01:15 pm | May 05, 2023
Lawmakers expressed concern that the DEA's plan to roll back flexibilities could make OUD medication more difficult to obtain.
By Jeff Lagasse | 11:25 am | May 04, 2023
Still, Eli Lilly is touting the results, which demonstrate effectiveness at slowing the progression of the disease.
By Susan Morse | 12:29 pm | May 03, 2023
Both cite as a reason the implications of a court overriding drug decisions by the FDA. 
HIMSS23
By HIMSS TV | 12:00 pm | May 02, 2023
Targeted medication alerts use genetic and EHR information to warn of treatment issues when it really matters, says Anna Dover, director of product management at First Databank.
By Susan Morse | 11:55 am | April 24, 2023
Big Pharma spends millions attempting to deflect blame, limit competition, and undermine patients' bargaining power, AHIP says.
By Susan Morse | 12:20 pm | March 29, 2023
The FDA has approved the first nonprescription OTC naloxone nasal spray, Narcan.
By Jeff Lagasse | 04:34 pm | March 28, 2023
The AG has alleged that Express Scripts has used its market dominance solely for its financial gain.
By Jeff Lagasse | 04:17 pm | March 17, 2023
The number of positions has grown from 5,127 in 2019 to 5,832 this year, a sign that the pipeline for new pharmacists is getting bigger.
By Susan Morse | 11:29 am | March 16, 2023
The first set of negotiations will occur during 2023 and 2024 and result in prices effective in 2026.